Nanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinoma von Hsueh, Chung-Tzu, Selim, Julie H, Tsai, James Y, Hsueh, Chung-Tsen

Volltext

Perianal basosquamous carcinoma treated with radiation therapy, a case report von Kwan, Stephanie Y, Castillo, Dani Ran, Aka, Allison A, Kandala, Gokul, Tsai, James Y, Zmaj, Kristine, Reeves, Mark E, Yang, Gary Y

Volltext

Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2 neu von Safran, Howard, Iannitti, David, Ramanathan, Ramesh, Schwartz, Jonathan D., Steinhoff, Margaret, Nauman, Chris, Hesketh, Paul, Rathore, Ritesh, Wolff, Robert, Tantravahi, Umadevi, Hughes, Marilyn, Maia, Chris, Pasquariello, Terry, Goldstein, Lisa, King, Thomas, Tsai, James Y., Kennedy, Teresa

Volltext

Effects of Chinese herbal medicine in combination with mitomycin C on gastric cancer cells von Kuo, Che-Chang, Chen, Jian-Jung, Tsai, James Y, Hsueh, Chung-Tsen

Volltext

Combined modality therapy for pancreatic cancer von Tsai, James Y, Iannitti, David A, Safran, Howard

Volltext

Trastuzumab, paclitaxel, cisplatin, and radiation for adenocarcinoma of the esophagus: a phase I study von Safran, Howard, DiPetrillo, Thomas, Nadeem, Ahmed, Steinhoff, Margaret, Tantravahi, Umadevi, Rathore, Ritesh, Wanebo, Harold, Hughes, Marilyn, Maia, Chris, Tsai, James Y, Pasquariello, Terry, Pepperell, John R, Cioffi, William, Kennedy, Teresa, Reeder, Laurie, Ng, Thomas, Adrian, Alyn, Goldstein, Lisa, Chak, Bapsi, Choy, Hak

Volltext

Status of treatment for advanced gastric carcinoma von Tsai, James Y, Safran, Howard

Volltext

HER-2 neu and p53 in Osteosarcoma: An Immunohistochemical and Fluorescence In Situ Hybridization Analysis von Tsai, James Y., Aviv, Hana, Benevenia, Joseph, Chang, Victor T., Patterson, Francis, Aisner, Seena, Hameed, Meera

Volltext

Paclitaxel and Concurrent Radiation in Upper Gastrointestinal Cancers von Constantinou, Maria, Tsai, James Y., Safran, Howard

Volltext

Phase I study of docetaxel, capecitabine, and carboplatin in metastatic esophagogastric cancer von Tsai, James Y, Iannitti, David, Berkenblit, Anna, Akerman, Paul, Nadeem, Ahmed, Rathore, Ritesh, Harrington, David, Roye, Dean, Miner, Thomas, Barnett, John M, Maia, Christine, Stuart, Keith, Safran, Howard

Volltext

Hemorrhagic ascites: an unusual manifestation of prostate carcinoma von Tsai, James Y, Ling, Matthew, Chang, Victor T, Hwang, Shirley S, Kasimis, Basil S

Volltext

Combined modality therapy for pancreatic cancer: Recent Advances in Combined Modality Therapy for Solid Tumors von TSAI, James Y, IANNITTI, David A, SAFRAN, Howard

Volltext

Changes in oscillatory dynamics in the cell cycle of early Xenopus laevis embryos von Tsai, Tony Y-C, Theriot, Julie A, Ferrell, Jr, James E

Volltext

Predicting suicide attempt or suicide death following a visit to psychiatric specialty care: A machine learning study using Swedish national registry data von Chen, Qi, Zhang-James, Yanli, Barnett, Eric J., Lichtenstein, Paul, Jokinen, Jussi, D'Onofrio, Brian M., Faraone, Stephen, Larsson, Henrik, Fazel, Seena

Volltext

Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan von Yu, Kuang‐Hui, Chen, Der‐Yuan, Chen, Jiunn‐Horng, Chen, Shih‐Yang, Chen, Shyh‐Ming, Cheng, Tien‐Tsai, Hsieh, Song‐Chou, Hsieh, Tsu‐Yi, Hsu, Pai‐Feng, Kuo, Chang‐Fu, Kuo, Mei‐Chuan, Lam, Hing‐Chung, Lee, I‐Te, Liang, Toong‐Hua, Lin, Hsiao‐Yi, Lin, Shih‐Chang, Tsai, Wen‐Pin, Tsay, Gregory J., Wei, James Cheng‐Chung, Yang, Chung‐Han, Tsai, Wen‐Chan

Volltext

Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy von Barkal, Amira A., Weiskopf, Kipp, Kao, Kevin S., Gordon, Sydney R., Rosental, Benyamin, Yiu, Ying Y., George, Benson M., Markovic, Maxim, Ring, Nan G., Tsai, Jonathan M., McKenna, Kelly M., Ho, Po Yi, Cheng, Robin Z., Chen, James Y., Barkal, Layla J., Ring, Aaron M., Weissman, Irving L., Maute, Roy L.

Volltext

Efficient Front-Rear Coupling in Neutrophil Chemotaxis by Dynamic Myosin II Localization von Tsai, Tony Y.-C., Collins, Sean R., Chan, Caleb K., Hadjitheodorou, Amalia, Lam, Pui-Ying, Lou, Sunny S., Yang, Hee Won, Jorgensen, Julianne, Ellett, Felix, Irimia, Daniel, Davidson, Michael W., Fischer, Robert S., Huttenlocher, Anna, Meyer, Tobias, Ferrell, James E., Theriot, Julie A.

Volltext

Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled tri... von Park, Keunchil, Prof, Tan, Eng-Huat, MD, O'Byrne, Ken, Prof, Zhang, Li, Prof, Boyer, Michael, Prof, Mok, Tony, Prof, Hirsh, Vera, Prof, Yang, James Chih-Hsin, Prof, Lee, Ki Hyeong, MD, Lu, Shun, Prof, Shi, Yuankai, MD, Kim, Sang-We, MD, Laskin, Janessa, MD, Kim, Dong-Wan, Prof, Arvis, Catherine Dubos, MD, Kölbeck, Karl, MD, Laurie, Scott A, MD, Tsai, Chun-Ming, Prof, Shahidi, Mehdi, MD, Kim, Miyoung, MD, Massey, Dan, PhD, Zazulina, Victoria, MD, Paz-Ares, Luis, MD

Volltext

COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets von Ziegler, Carly G. K., Heimberg, Graham, Normand, Rachelly, Yang, Yiming, Segerstolpe, Åsa, Abbondanza, Domenic, Fleming, Stephen J., Montoro, Daniel T., Jagadeesh, Karthik A., Dey, Kushal K., Sen, Pritha, Slyper, Michal, Pita-Juárez, Yered H., Phillips, Devan, Biermann, Jana, Bloom-Ackermann, Zohar, Barkas, Nikolaos, Ganna, Andrea, Gomez, James, Melms, Johannes C., Katsyv, Igor, Normandin, Erica, Naderi, Pourya, Popov, Yury V., Raju, Siddharth S., Niezen, Sebastian, Tsai, Linus T.-Y., Siddle, Katherine J., Sud, Malika, Tran, Victoria M., Vellarikkal, Shamsudheen K., Wang, Yiping, Amir-Zilberstein, Liat, Atri, Deepak S., Beechem, Joseph, Brook, Olga R., Chen, Jonathan, Divakar, Prajan, Engreitz, Jesse M., Essene, Adam, Fitzgerald, Donna M., Fropf, Robin, Gazal, Steven, Gould, Joshua, Grzyb, John, Harvey, Tyler, Hether, Tyler, Jané-Valbuena, Judit, Leney-Greene, Michael, Ma, Hui, McCabe, Cristin, McLoughlin, Daniel E., Miller, Eric M., Muus, Christoph, Niemi, Mari, Padera, Robert, Pan, Liuliu, Pant, Deepti, Pe’er, Carmel, Pfiffner-Borges, Jenna, Pinto, Christopher J., Plaisted, Jacob, Reeves, Jason, Ross, Marty, Rudy, Melissa, Rueckert, Erroll H., Siciliano, Michelle, Sturm, Alexander, Waghray, Avinash, Warren, Sarah, Zhang, Shuting, Zollinger, Daniel R., Cosimi, Lisa, Gupta, Rajat M., Hacohen, Nir, Hibshoosh, Hanina, Hide, Winston, Price, Alkes L., Rajagopal, Jayaraj, Tata, Purushothama Rao, Riedel, Stefan, Szabo, Gyongyi, Tickle, Timothy L., Hung, Deborah, Sabeti, Pardis C., Novak, Richard, Rogers, Robert, Ingber, Donald E., Jiang, Z. Gordon, Juric, Dejan, Izar, Benjamin, Stone, James R., Vlachos, Ioannis S., Solomon, Isaac H., Ashenberg, Orr, Porter, Caroline B. M., Li, Bo, Shalek, Alex K., Villani, Alexandra-Chloé, Regev, Aviv

Volltext

Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial von Reich, Kristian, Gooderham, Melinda, Thaçi, Diamant, Crowley, Jeffrey J, Ryan, Caitriona, Krueger, James G, Tsai, Tsen-Fang, Flack, Mary, Gu, Yihua, Williams, David A, Thompson, Elizabeth H Z, Paul, Carle

Volltext